RDF/XMLNTriplesTurtleShow queryShare
SubjectPredicateObject
http://purl.uniprot.org/citations/37672963http://www.w3.org/1999/02/22-rdf-syntax-ns#typehttp://purl.uniprot.org/core/Journal_Citation
http://purl.uniprot.org/citations/37672963http://www.w3.org/2000/01/rdf-schema#comment"

Background

The SOCS proteins act as suppressors of cytokine signaling by impeding certain signaling pathways. SOCS5, a constituent of the SOCS family, has been associated with the management of allergic reactions, primarily by impeding the signaling of interleukin-4 (IL-4), which is known to have a cardinal function in accelerating the development of an allergic reaction. The key goal of our research was to explore the probable ramifications of the SOCS5 single nucleotide polymorphism (SNP) namely rs41379147 on the expression of SOCS5 mRNA and serum IL-12 levels, as well as to analyze the interaction between SOCS5 genotypes and various clinicopathological parameters in atopic diseases.

Methods

The study involved the enrollment of 314 subjects comprising 154 atopic individuals and 160 healthy controls. PCR-RFLP was employed to conduct SNP analysis. Real-Time PCR was employed to quantify SOCS5 mRNA. The enzyme-linked immunosorbent assay (ELISA) technique was used for the quantification of interleukin-12 and total IgE levels in the serum while as chemiluminescence was used to determine Vitamin D levels.

Results

The PCR-RFLP analysis indicated a lack of statistically significant variation in genotypic and allelic frequencies between the cases and controls (p > 0.05) for - 9147 C/T SNP either in total atopy (OR-0.70, 95% CI=0.43-1.12, p =0.15), and on subgroup stratifications of chronic urticaria (OR-0.81, 95 % CI = 0.42-1.59, p = 0.61), allergic rhinitis (OR-0.63, 95 % CI = 0.33-1.19, p = 0.16) and bronchial asthma (OR-0.66,95% CI = 0.29-1.4, p=0.32). There was reduced mRNA expression of SOCS5 in total atopic cases, allergic rhinitis, bronchial asthma and chronic urticaria in comparison to controls which advocates the fact that SOCS5 has a protective role in allergic disease development. Despite the reduced amounts of IL-12 in total atopic cases and different allergic disorders in comparison to controls, IL-12 showed significant positive correlation with SOCS5 mRNA expression (p < 0.05).

Conclusion

SOCS5 SNP rs41379147(C/T) does not pose any significant risk towards the development of any allergic disorder and has no impact on the expression of SOCS5 and IL-12. Our study has shown the reduced mRNA expression of SOCS5 among individuals diagnosed with chronic urticaria, allergic rhinitis and bronchial asthma and the expression of SOCS5 showed complete dependence on the cytokine milieu of IL12. The modulation of SOCS5 and IL-12 may represent potential curative targets for treating the menace of allergic diseases and present promising avenues for future investigation."xsd:string
http://purl.uniprot.org/citations/37672963http://purl.org/dc/terms/identifier"doi:10.1016/j.molimm.2023.08.011"xsd:string
http://purl.uniprot.org/citations/37672963http://purl.uniprot.org/core/author"Hussain S."xsd:string
http://purl.uniprot.org/citations/37672963http://purl.uniprot.org/core/author"Shafi T."xsd:string
http://purl.uniprot.org/citations/37672963http://purl.uniprot.org/core/author"Rasool R."xsd:string
http://purl.uniprot.org/citations/37672963http://purl.uniprot.org/core/author"Jan R."xsd:string
http://purl.uniprot.org/citations/37672963http://purl.uniprot.org/core/author"Shah Z.A."xsd:string
http://purl.uniprot.org/citations/37672963http://purl.uniprot.org/core/author"Gull A."xsd:string
http://purl.uniprot.org/citations/37672963http://purl.uniprot.org/core/author"Qureshi T.A."xsd:string
http://purl.uniprot.org/citations/37672963http://purl.uniprot.org/core/date"2023"xsd:gYear
http://purl.uniprot.org/citations/37672963http://purl.uniprot.org/core/name"Mol Immunol"xsd:string
http://purl.uniprot.org/citations/37672963http://purl.uniprot.org/core/pages"102-110"xsd:string
http://purl.uniprot.org/citations/37672963http://purl.uniprot.org/core/title"Evaluation of SOCS5 mRNA and its association with serum IL-12 levels and rs41379147 SNP in various subsets of allergic disorders: A case control study."xsd:string
http://purl.uniprot.org/citations/37672963http://purl.uniprot.org/core/volume"162"xsd:string
http://purl.uniprot.org/citations/37672963http://www.w3.org/2004/02/skos/core#exactMatchhttp://purl.uniprot.org/pubmed/37672963
http://purl.uniprot.org/citations/37672963http://xmlns.com/foaf/0.1/primaryTopicOfhttps://pubmed.ncbi.nlm.nih.gov/37672963
http://purl.uniprot.org/uniprot/#_B4DL10-mappedCitation-37672963http://www.w3.org/1999/02/22-rdf-syntax-ns#objecthttp://purl.uniprot.org/citations/37672963
http://purl.uniprot.org/uniprot/#_O75159-mappedCitation-37672963http://www.w3.org/1999/02/22-rdf-syntax-ns#objecthttp://purl.uniprot.org/citations/37672963
http://purl.uniprot.org/uniprot/B4DL10http://purl.uniprot.org/core/mappedCitationhttp://purl.uniprot.org/citations/37672963
http://purl.uniprot.org/uniprot/O75159http://purl.uniprot.org/core/mappedCitationhttp://purl.uniprot.org/citations/37672963